ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity.

Mohammed Khurshed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.